Susquehanna International Group, LLP Omeros Corp Transaction History

Susquehanna International Group, LLP

  • $560 Billion
  • Q3 2024

A detailed history of Susquehanna International Group, LLP transactions in Omeros Corp stock. As of the latest transaction made, Susquehanna International Group, LLP holds 30,268 shares of OMER stock, worth $225,799. This represents 0.0% of its overall portfolio holdings.

Number of Shares
30,268
Previous 54,555 44.52%
Holding current value
$225,799
Previous $221,000 45.7%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$3.54 - $5.47 $85,975 - $132,849
-24,287 Reduced 44.52%
30,268 $120,000
Q2 2024

Aug 15, 2024
BUY
$3.04 - $4.23 $2,666 - $3,709
877 Added 1.63%
54,555 $221,000
Q1 2024

May 07, 2024
SELL
$2.88 - $4.89 $172,874 - $293,527
-60,026 Reduced 52.79%
53,678 $185,000
Q4 2023

Feb 14, 2024
SELL
$1.08 - $3.63 $66,984 - $225,143
-62,023 Reduced 35.3%
113,704 $371,000
Q3 2023

Nov 14, 2023
BUY
$2.81 - $5.69 $95,399 - $193,175
33,950 Added 23.95%
175,727 $513,000
Q2 2023

Aug 11, 2023
SELL
$4.45 - $7.57 $948,303 - $1.61 Million
-213,102 Reduced 60.05%
141,777 $771,000
Q1 2023

May 16, 2023
BUY
$2.48 - $5.22 $77,420 - $162,957
31,218 Added 9.65%
354,879 $1.65 Million
Q4 2022

Feb 14, 2023
BUY
$1.75 - $3.96 $271,264 - $613,831
155,008 Added 91.91%
323,661 $731,000
Q3 2022

Nov 14, 2022
BUY
$3.09 - $7.46 $45,444 - $109,714
14,707 Added 9.55%
168,653 $531,000
Q2 2022

Aug 15, 2022
SELL
$1.92 - $6.28 $14,161 - $46,321
-7,376 Reduced 4.57%
153,946 $423,000
Q1 2022

May 16, 2022
SELL
$5.07 - $7.2 $624,269 - $886,536
-123,130 Reduced 43.29%
161,322 $970,000
Q4 2021

Feb 14, 2022
BUY
$5.67 - $8.54 $250,120 - $376,725
44,113 Added 18.35%
284,452 $1.83 Million
Q3 2021

Nov 15, 2021
BUY
$13.4 - $16.3 $469,897 - $571,592
35,067 Added 17.08%
240,339 $3.31 Million
Q2 2021

Aug 11, 2021
BUY
$14.81 - $19.13 $519,594 - $671,156
35,084 Added 20.61%
205,272 $3.05 Million
Q1 2021

May 17, 2021
SELL
$14.52 - $23.53 $1.92 Million - $3.12 Million
-132,462 Reduced 43.77%
170,188 $3.03 Million
Q4 2020

Feb 16, 2021
SELL
$10.14 - $15.19 $355,701 - $532,850
-35,079 Reduced 10.39%
302,650 $4.32 Million
Q3 2020

Nov 16, 2020
BUY
$9.57 - $21.32 $2 Million - $4.46 Million
209,366 Added 163.1%
337,729 $3.41 Million
Q2 2020

Aug 14, 2020
BUY
$12.21 - $16.99 $360,402 - $501,493
29,517 Added 29.86%
128,363 $1.89 Million
Q1 2020

May 15, 2020
SELL
$9.03 - $19.72 $686,289 - $1.5 Million
-76,001 Reduced 43.47%
98,846 $1.32 Million
Q3 2019

Nov 14, 2019
BUY
$14.55 - $20.56 $944,120 - $1.33 Million
64,888 Added 59.01%
174,847 $2.86 Million
Q2 2019

Aug 16, 2019
BUY
$15.0 - $19.62 $91,245 - $119,348
6,083 Added 5.86%
109,959 $1.73 Million
Q2 2019

Aug 14, 2019
SELL
$15.0 - $19.62 $39,735 - $51,973
-2,649 Reduced 2.49%
103,876 $1.63 Million
Q1 2019

May 15, 2019
SELL
$11.65 - $17.72 $414,239 - $630,070
-35,557 Reduced 25.03%
106,525 $1.85 Million
Q4 2018

Feb 14, 2019
SELL
$10.72 - $16.73 $5.83 Million - $9.1 Million
-543,794 Reduced 79.28%
142,082 $1.58 Million
Q3 2018

Nov 14, 2018
SELL
$17.73 - $26.69 $4.77 Million - $7.19 Million
-269,267 Reduced 28.19%
685,876 $16.7 Million
Q2 2018

Aug 14, 2018
BUY
$10.79 - $24.44 $1.71 Million - $3.86 Million
158,052 Added 19.83%
955,143 $17.3 Million
Q1 2018

May 15, 2018
SELL
$9.0 - $20.16 $5.61 Million - $12.6 Million
-622,953 Reduced 43.87%
797,091 $8.9 Million
Q4 2017

Feb 14, 2018
BUY
$13.26 - $22.86 $9.47 Million - $16.3 Million
714,232 Added 101.19%
1,420,044 $27.6 Million
Q3 2017

Nov 14, 2017
BUY
$19.76 - $24.9 $13.9 Million - $17.6 Million
705,812
705,812 $15.3 Million

Others Institutions Holding OMER

# of Institutions
120
Shares Held
25.6M
Call Options Held
228K
Put Options Held
630K
View Full List

About OMEROS CORP

OMER Quotes by TradingView
  • Ticker OMER
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,730,000
  • Market Cap $468M
  • Description
  • Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...
More about OMER
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email